Copyright
©The Author(s) 2017.
World J Diabetes. Apr 15, 2017; 8(4): 154-164
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.154
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.154
Measured SMBG (mmol/L) | Baseline | Intervention | Follow-up |
Morning SMBG by phase | |||
< 7.0 | 13.8% | 34.1% | 15.1% |
7.0-9.05 | 52.0% | 40.7% | 49.6% |
9.05-11.1 | 33.3% | 18.0% | 32.8% |
> 11.1 | 0.8% | 7.1% | 2.5% |
Evening SMBG by phase | |||
< 7.0 | 24.5% | 27.7% | 12.9% |
7.0-9.05 | 28.1% | 32.9% | 41.6% |
9.05-11.1 | 27.4% | 19.7% | 28.7% |
> 11.1 | 20.0% | 19.7% | 16.8% |
- Citation: Arnason TG, Bowen MW, Mansell KD. Effects of intermittent fasting on health markers in those with type 2 diabetes: A pilot study. World J Diabetes 2017; 8(4): 154-164
- URL: https://www.wjgnet.com/1948-9358/full/v8/i4/154.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i4.154